Modulation of endothelial cell activation in sickle cell disease: A pilot study

Blood

Volumn 97, Issue 7, 2001, Pages 1937-1941

  Solovey, Alex A ^a   Solovey, Anna N ^a   Harkness, Jeanne ^a   Hebbel, Robert P ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; SALAZOSULFAPYRIDINE; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE REPORT; CELL ACTIVATION; DOWN REGULATION; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MODULATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TREATMENT OUTCOME;

EID: 0035312965     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.7.1937     Document Type: Article

References (27)

1. The endothelial biology of sickle cell disease
2. Pathogenesis of vasoocclusion
3. Adhesive interactions of sickle erythrocytes with endothelium
4. Circulating activated endothelial cells in sickle cell anemia
5. Tissue factor expression by endothelial cells in sickle cell anemia
6. The role of endothelial cells in inflammation
7. Reperfusion injury pathophysiology in sickle transgenic mice
8. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice
9. Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
10. NF-κB and rel proteins: Evolutionarily conserved mediators of immune responses
11. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
12. S- and alpha-globins in transgenic mice: Erythrocyte abnormalities, organ damage, and the effect of hypoxia
13. Endothelial cells in physiology and in the pathophysiology of vascular disorders
14. Regulation of the tissue factor gene
15. Regulation of the tissue factor promoter in endothelial cells
16. The effect of sodium salicylate and aspirin on NF-κB
17. Immunosuppression by glucocodicoids: Inhibition of NF-κB activity through induction of IkB synthesis
18. Inhibition of NK-κB by sodium salicylate and aspirin
19. An in vivo cytokine and endotoxin-independent pathway for induction of nitric oxide synthase II mRNA, enzyme, and nitrate/nitrite in alveolar macrophages
20. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras
21. Central nervous system DNA fragmentation induced by the inhibition of nuclear factor kappa B
22. In vivo transfection of cis element "decoy" against nuclear factor-kB binding site prevents myocardial infarction
23. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease
24. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome
25. Therapeutic modulation of vascular endothelial cell activation state as therapy for sickle cell disease: NF-κB inhibition as a strategy
26. Activated monocytes in sickle cell disease: Potential role in the activation of vascular endothelium and vaso-occlusion
27. Atherosclerosis: An inflammatory disease